Fennec Pharma Competitors and Similar CompaniesClear all
Fennec Pharma's competitors and similar companies include LadRx and Repertoire Immune Medicines.
 Fennec Pharma Fennec Pharmaceuticals is a biotechnology company focused on the development of Sodium Thiosulfate for the prevention of ototoxicity from cisplatin in pediatric patients. |  LadRx LadRx Corporation (formerly known as CytRx Corporation) is a biopharmaceutical company focused on discovering, developing and commercializing new therapeutics to treat patients with cancer. |  Repertoire Immune Medicines Repertoire Immune Medicines is a biotechnology company tapping the curative powers of the immune system to prevent, treat, or cure cancer, autoimmune conditions, and infectious diseases. | |
Founding Date | Founding Date 1996 | Founding Date 1985 | Founding Date 2015 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations US HQ | Locations Los Angeles, US HQ | Locations Cambridge, US HQ Schlieren, CH Cambridge, US |
Employees | Employees 433% increase | Employees 385% decrease | Employees 887% increase |
Valuation ($) | Valuation ($) 129.4 m | Valuation ($) 901.1 k | Valuation ($) N/A |
Financial | |||
Net income | Net income ($9.7m) (FY, 2025) | Net income ($1.6m) (FY, 2024) | Net income N/A |
For sources of this data, please see the company profile
View Company Profiles
LadRx
HQ
Los Angeles, US
Employees
3
LadRx Corporation (formerly known as CytRx Corporation) is a biopharmaceutical company focused on discovering, developing and commercializing new therapeutics to treat patients with cancer.
View companyRepertoire Immune Medicines
HQ
Cambridge, US
Employees
88↑ 7% increase
Repertoire Immune Medicines is a biotechnology company tapping the curative powers of the immune system to prevent, treat, or cure cancer, autoimmune conditions, and infectious diseases.
View company